País: Reino Unido
Língua: inglês
Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)
Hexylresorcinol
Omega Pharma Ltd
R02AA12
Hexylresorcinol
2.4mg
Lozenge
Oromucosal
No Controlled Drug Status
Valid as a prescribable product
BNF: 12030300; GTIN: 5012616171406
READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. THIS MEDICINE IS AVAILABLE WITHOUT PRESCRIPTION. HOWEVER, YOU STILL NEED TO USE TCP SORE THROAT LOZENGES CAREFULLY TO GET THE BEST RESULTS FROM IT. ✓ Keep this leaflet. You may need to read it again. ✓ Ask your pharmacist if you need more information or advice. ✓ You must contact a doctor if your symptoms worsen or do not improve. ✓ If you notice any side effects, please tell your doctor or pharmacist. In this leaflet: 1. What TCP Sore Throat Lozenges are and what they are used for 2. Before you take TCP Sore Throat Lozenges 3. How to take TCP Sore Throat Lozenges 4. Possible side effects 5. Storing TCP Sore Throat Lozenges 6. Further information 1. What TCP Sore Throat Lozenges are and what they are used for TCP Sore Throat Lozenges contain a local anaesthetic to soothe the pain and discomfort of sore throats with an antiseptic action to fight the bacterial infection that can cause sore throats. 2. BEFORE YOU TAKE TCP SORE THROAT LOZENGES DO NOT TAKE THIS MEDICINE IF: ✓ you are allergic (hypersensitive) to any of the ingredients of TCP Sore Throat Lozenges (see section 6) ✓ it is for a child younger than 6 years. Taking other medicines TCP Sore Throat Lozenges are not known to interfere with other medicines. Pregnancy and Breastfeeding As with all medicines, ask your doctor or pharmacist for advice before using TCP Sore Throat Lozenges during pregnancy or when breastfeeding. Important information about some of the ingredients of TCP Sore Throat Lozenges If you have been told by your doctor that you or your child has an intolerance to some sugars, consult your doctor before using TCP Sore Throat Lozenges. TCP SORE THROAT LOZENGES P A T I E N T I N F O R M A T I O N L E A F L E T FINAL ARTWORK TCP Sore Throat Lozenges PIL x24 UK DATE: 18/12/12 PMS 314 PMS Black 136 x 200 mm Cutter COLOURS SIZE 3. HOW TO TAKE TCP SORE THROAT LOZENGES TCP Sore Throat Lozenges can be used by adults, the elderly and by children over 6 yea Leia o documento completo
OBJECT 1 TCP SORE THROAT LOZENGE Summary of Product Characteristics Updated 19-Sep-2014 | Omega Pharma Ltd 1. Name of the medicinal product TCP Sore Throat Lozenge Buttercup Max Strength Sore Throat Lozenge 2. Qualitative and quantitative composition Each lozenge contains hexylresorcinol 2.4mg. 3. Pharmaceutical form Lozenge 4. Clinical particulars 4.1 Therapeutic indications As an antiseptic, demulcent and local anaesthetic for the relief of sore throat and its associated pain. 4.2 Posology and method of administration Route of administration: oral. Adults, elderly and children 6 years and over: One lozenge dissolved slowly in the mouth every three hours or as required. Do not take more than 12 lozenges in 24 hours. Not to be given to children under 6 years. 4.3 Contraindications Hypersensitivity to any of the ingredients. 4.4 Special warnings and precautions for use Keep out of reach of children. If symptoms persist, consult your doctor. Not to be given to children under 6 years (warnings on the labelling). 4.5 Interaction with other medicinal products and other forms of interaction None known. 4.6 Pregnancy and lactation The product is not contra-indicated during pregnancy and lactation. However as with all medicines during this period, caution should be exercised. 4.7 Effects on ability to drive and use machines None known. 4.8 Undesirable effects None known. 4.9 Overdose Hexylresorcinol overdosage may cause minor gastro-intestinal irritation. 5. Pharmacological properties 5.1 Pharmacodynamic properties Hexylresorcinol is a local anaesthetic for topical use on the mucous membranes of the mouth and throat. Mild antiseptic activity has also been demonstrated. 5.2 Pharmacokinetic properties Pharmacokinetic considerations do not arise since the pharmacological action is local to the oropharyngeal cavity. 5.3 Preclinical safety data No specific data. 6. Pharmaceutical particulars 6.1 List of excipients Menthol Laevo Eucalyptus Oil Quinoline Yellow E104 Acid Brilliant Green BS E142 Sucrose/Liquid Glucose Solids 6.2 Leia o documento completo